Correspondence

Circular 004/2022: Gamma-Butyrolactone (GBL) and 1,4-Butanediol (1,4-BD): revocation of rescheduling

The Misuse of Drugs (Amendment) (Revocation) (England, Wales and Scotland) Regulations 2022 (SI 2022 No. 559) (“the 2022 Regulations”).

• From: Home Office
• Published: 14 June 2022

Documents

Circular 004/2022: Gamma-Butyrolactone (GBL) and 1,4-Butanediol (1,4-BD): revocation of rescheduling

HTML

Details

This circular draws attention to the contents of the below Statutory Instrument, which will come into force on 14 June 2022:

• The Misuse of Drugs (Amendment) (Revocation) (England, Wales and Scotland) Regulations 2022 (SI 2022 No. 559) (“the 2022 Regulations”)

Published 14 June 2022